
---
nice.evidencecategory: 
---

### Evidence Statement CG66ES112
A Cochrane review237 did not find a statistically significant reduction in the risk of all-cause
mortality in the five studies (3,409 patients) of A2RB vs placebo/no treatment. RR 0.99, 95% CI
0.85 to 1.17. Level 1++

[@2005]

